Detalhe da pesquisa
1.
Joint involvement in sarcoidosis: systematic review and meta-analysis of prevalence, clinical pattern and outcome.
Rheumatology (Oxford)
; 2024 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38281070
2.
Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial.
Rheumatology (Oxford)
; 2024 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38652570
3.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford)
; 2024 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38460548
4.
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 81-94, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36410794
5.
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 95-106, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36368906
6.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36357155
7.
Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative.
Clin Exp Rheumatol
; 41(1): 118-125, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35616591
8.
"From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ).
Qual Life Res
; 32(5): 1307-1318, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36074252
9.
Current and future status of JAK inhibitors.
Lancet
; 398(10302): 803-816, 2021 08 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34454676
10.
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
Ann Rheum Dis
; 81(11): 1491-1503, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35922124
11.
Healthcare utilization and economic burden in systemic sclerosis: a systematic review.
Rheumatology (Oxford)
; 61(8): 3123-3131, 2022 08 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34849627
12.
Prevalence of osteoporosis in osteoarthritis: a systematic review and meta-analysis.
Osteoporos Int
; 33(8): 1687-1693, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35380214
13.
The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis.
Clin Exp Rheumatol
; 40(7): 1411-1416, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34596032
14.
Scleroderma epidemiology update.
Curr Opin Rheumatol
; 33(2): 122-127, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33481429
15.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Ann Rheum Dis
; 80(1): 71-87, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33158881
16.
Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
Rheumatology (Oxford)
; 60(2): 717-727, 2021 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32789456
17.
Ocular manifestations of Behçet's disease in children and adults: a systematic review and meta-analysis.
Clin Exp Rheumatol
; 39 Suppl 132(5): 94-101, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34596037
18.
Guidelines on prescribing and monitoring antimalarials in rheumatic diseases: a systematic review.
Clin Exp Rheumatol
; 39(2): 407-412, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33124575
19.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial.
Ann Rheum Dis
; 79(5): 618-625, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32299845
20.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Ann Rheum Dis
; 79(6): 685-699, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31969328